Article Details

Eli Lilly Can't Slip Teva's Migraine Drug Patent Suit - Law360

Retrieved on: 2022-10-04 22:18:09

Tags for this article:

Click the tags to see associated articles and topics

Eli Lilly Can't Slip Teva's Migraine Drug Patent Suit - Law360. View article details on hiswai:

Excerpt

Lilly must still face most of the claims that it willfully infringed Teva's patents for monoclonal antibody treatment of headaches when it brought ...

Article found on: www.law360.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up